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Abstract
Postoperative cognitive decline (POCD) is a common complication following surgery, but its aetiology remains unclear. We
hypothesized that xenon pretreatment prevents POCD by suppressing the systemic inflammatory response or through an
associated protective signaling pathway involving heat shock protein 72 (Hsp72) and PI3-kinase. Twenty-four hours after
establishing long-term memory using fear conditioning training, C57BL/6 adult male mice (n = 12/group) received one of
the following treatments: 1) no treatment group (control); 2) 1.8% isoflurane anesthesia; 3) 70% xenon anesthesia; 4) 1.8%
isoflurane anesthesia with surgery of the right hind leg tibia that was pinned and fractured; or 5) pretreatment with 70%
xenon for 20 minutes followed immediately by 1.8% isoflurane anesthesia with the surgery described above. Assessments
of hippocampal-dependent memory were performed on days 1 and 7 after treatment. Hsp72 and PI3-kinase in
hippocampus, and plasma IL-1b, were measured using western blotting and ELISA respectively, from different cohorts on
day 1 after surgery. Isoflurane induced memory deficit after surgery was attenuated by xenon pretreatment. Xenon
pretreatment prevented the memory deficit typically seen on day 1 (P = 0.04) but not on day 7 (P = 0.69) after surgery under
isoflurane anesthesia, when compared with animals that underwent surgery without pretreatment. Xenon pretreatment
modulated the expression of Hsp72 (P = 0.054) but had no significant effect on PI3-kinase (P = 0.54), when compared to
control. Xenon pretreatment also reduced the plasma level increase of IL-1b induced by surgery (P = 0.028). Our data
indicated that surgery and/or Isoflurane induced memory deficit was attenuated by xenon pretreatment. This was
associated with a reduction in the plasma level of IL-1b and an upregulation of Hsp72 in the hippocampus.
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Introduction
Postoperative cognitive decline (POCD) is a frequent compli-
cation of major surgery in the elderly [1], with an incidence of up
to 56% [2]. However, the pathogenesis and molecular mecha-
nisms underlying POCD have so far remained unclear. Risk
factors for POCD include increasing age, preoperative cognitive
dysfunction and perioperative infection [2,3,4]. Central inflam-
matory responses, specifically cytokine increases in the hippocam-
pus following surgery, have been reported in rat and mouse
models of POCD [5,6]. Increase in hippocampal IL-1b is
suggested to play a role in the onset of a memory deficit following
infection [7,8,9]. Furthermore, the possible contributory role of
anesthesia and analgesia in the development of POCD remains ill
defined [10].
Physiologically protective mechanisms may prevent or alter
neuroinflammatory changes and could influence the development
of POCD [11,12]. For example, cytosolic heat shock protein 72
(Hsp72) is readily induced by stress and has cellular protective
functions [13]. Studies of in vitro and in vivo models of stroke have
demonstrated that injury can be reduced by Hsp72 over-
expression [11]. Hsp72 over expression was also found to be
associated with a reduced activation of the pro-inflammatory
transcription factor NF-kB [14]. Our previous study showed that
transgenic over expression of Hsp72 was associated with better
preservation of memory following tibial fracture surgery [15].
Anesthetics including xenon and isoflurane also have effects on
cellular signaling that may mediate their organoprotective
properties [16].
Xenon has been found to confer neuroprotection in animal
models of cerebral ischemia [17], cardiopulmonary bypass
[18,19], and post-cardiac arrest [20]. One mechanism by which
xenon exerts such effects is by inducing hypoxia inducible factor
one alpha, (HIF-1a) [17] which can interfere with apoptotic
signaling pathways [21,22]. To our knowledge, there are no data
in the literature that describe the effects of xenon on stress
proteins, including Hsp72, or its role in the prevention of
postoperative memory decline.
The aim of our current study was to investigate whether xenon
pretreatment could prevent or reduce memory impairment
following surgery in mice. We hypothesized that xenon pretreat-
ment would have such an effect due to a reduction in the systemic
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inflammation associated with upregulation of cytoplasmic Hsp72,
via the PI3-kinase pathway.
Results
All animals were trained prior to treatment. Memory acquisi-
tion by association was achieved by trial 4 and consolidated by
trial 6 of paired conditional - unconditional stimuli (CS - US)
during a single training session. Asymptotic performance was
achieved by the end of the sixth pair of CS – US stimuli (Figure 1).
The mean % freezing time during the acclimatization period was
1065% increasing to 6369% by the sixth pair of stimuli. There
were no statistically significant differences between the experi-
mental animal groups prior to surgery in either acquisition or
memory formation during the conditional response, trace interval,
unconditional response and inter-pair intervals during training
(data not shown).
Effects of Surgery on Behavior
The surgery under isoflurane anesthesia group showed reduced
memory on day 1 when compare with control, P = 0.001 (Table 1).
Mice preconditioned with xenon prior to surgery did not show
significant memory impairment on day 1. Their memory retention
was significantly better than the surgical group with no
pretreatment, P= 0.044 (Figure 2 and Table 1).
By day 7, there was no difference in retrieval of hippocampal
dependent memory between the two surgical groups, P = 0.69.
However, the surgical group that had not received xenon
pretreatment exhibited reduced memory retention as compared
to control, P = 0.018 (Figure 2 and Table 1).
Hippocampal-independent memory
Freezing behavior during the conditional stimulus assesses
hippocampal independent memory involving brain regions
including the prefrontal cortex and amygdala. We assessed the
dependence of the non-conditional response (tone) to treatments
on days 1 and 7. We found that surgery under isoflurane
anesthesia caused a reduction in freezing time on day 1 as
compared to control, P = 0.034. By day 7, animals showed
memory decline when compared to control: 1.8% Iso (P= 0.012),
1.8% Iso-S (P = 0.052) and Xe-Iso-S (P= 0.017).
The variability in hippocampal dependent memory was
minimal compared to that of hippocampal independent memory,
where more inter-animal variability was seen within the groups
(Table 2).
PI3-kinase and Hsp72 analysis
Hippocampi of 4 mice out of 6 per group were analyzed for PI3-
kinase on day 1 after treatment. Tissue from 2 animals per group
were not analyzed due to technical problems with western blotting
membrane. There was greater expression of PI3-kinase expression
on day 1 in mice exposed to xenon pretreatment prior to surgery
as compared to the control group, but this did not reach to a
statistical significance (P= 0.54) (Figure 3).
Hippocampi from 6 mice/group were assessed for Hsp72. The
Hsp72 expression was elevated in the Xe-pretreat-Iso-S group on
day 1 after treatment. Expression of Hsp72 in the hippocampi of
Xe-pretreat-Iso-S group showed a positive modulation compared
to that in the control group (1.760.2) (P = 0.054). There was also
difference between Xe-pretreat-Iso-S and 1.8% Iso-S on day 1
after treatment (P = 0.06) (Figure 4).
IL-1b analysis
Plasma IL-1b levels were measured on day 1 after treatment.
IL-1b plasma levels were 8.4360.7 pg/ml in the control,
41.566.8 pg/ml in the Xe-pretreat-Iso-S (P= 0.137) and
77.3614.6 pg/ml in the 1.8% Iso-S groups (P= 0.0005). There
was a significant difference between the Xe-pretreat-Iso-S and
1.8% Iso-S groups (P= 0.028). The 1.8% Iso-S anesthesia group
also had significant difference in plasma level of IL-1b when
compared to 70% Xe anesthesia and control groups, on day 1
after treatment (P = 0.0005), and 1.8% Iso (P= 0.026) (Figure 5).
Discussion
The results of our current study suggest that early postoperative
memory decline after surgery under isoflurane anesthesia is
ameliorated by xenon exposure immediately prior to surgical
intervention. This is associated with an upregulation of Hsp72
expression and PI3-kinase in the hippocampus and a decrease in
the plasma levels of IL-1b. Our data also suggest that the
detrimental effect is due to anesthesia in our animal model, which
is rescued by pretreatment of the animal with xenon.
We previously reported that no memory decline was seen after
tibial fracture surgery under general isoflurane anesthesia in
Hsp72-overexpressing transgenic mice [15]. Thermal and chem-
Figure 1. Learning and memory retrieval using fear condition-
ing paradigm. Memory acquisition was achieved by trial 4 and
asymptotic performance was achieved by trial 6 during a single training
session.
doi:10.1371/journal.pone.0026394.g001
Table 1. Hippocampal dependent memory: Contextual
conditional response was assessed by % freezing time.
Control 1.8% Iso 70% Xe 1.8% Iso-S
Xe-Pretreat-
Iso-S
Day 1 42.063.8% 22.164.7% 33.365.2% 119.661.8% 1132.162.6%
Day 7 37.164.4% 25.963.3% 37.363.9% %21.961.9% 28.162.4%
Data is presented as mean 6 SEM. Day 1: 1 P= 0.001 compared to control,
11P= 0.044 compared to Iso-S. Day 7: %P= 0.018 compared to control.
1.8% Iso = 1.8% isoflurane anesthesia treatment, 70% Xe= 70% xenon treatment,
1.8% Iso-S = 1.8% isoflurane surgery treatment, Xe-Pretreat-Iso-S = xenon
pretreatment +1.8% isoflurane anesthesia for surgery group.
doi:10.1371/journal.pone.0026394.t001
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ical-induced Hsp72 preconditioning in a rat heatstroke model has
been shown to have protective effects that correlate with specific
anatomical and histological changes in the brain [23]. In line with
our study, previous work has shown that upregulation of Hsp72
prior to myocardial ischemia confers cardioprotection as reflected
by reduced markers of cellular damage and improved functional
recovery [24]. Short periods of xenon treatment have been clearly
shown to upregulate several pro-survival proteins including Bcl-2
[25,26], and HIF-1a [17,27]. Our data suggest that the increase in
expression of Hsp72 24 hours after exposure to xenon might be an
important molecular mechanism by which xenon prevents
memory decline in the early postoperative period. Moreover, the
attenuation of cognitive decline following surgery through xenon
pretreatment is also likely to be due to its activation of the PI3-
kinase pathway.
Xenon pretreatment was shown to inhibit the elevation of
cytokine IL-1b in plasma after surgery. Xenon pretreatment may
only have effect on proteins already synthesized or stored, ready to
be released or expressed in the event of an insult, as a response to
stress. Preconditioning may be considered to prepare the cells for a
major insult by modifying protein synthesis. Consistent with our
observation, a clinical study showed that xenon seems to confer
protective effects by inhibition of platelets and leucocytes
activation during cardiopulmonary bypass in humans [28]. It
has also been shown that xenon has anti-inflammatory effects
including reducing plasma levels of tumor necrosis factor-1 alpha
(TNF-1a) and interleukin-6 (IL-6) after myocardial injury in a
porcine model of right ventricular infarction [29]. This anti-
inflammatory effect of xenon is likely to contribute to its beneficial
effects. The neuroinflammatory response is likely to be a key
mechanism in cognitive decline after surgery, as demonstrated
clearly by our group and others [5,6,30]. Recent work in
immortalized microglia stimulated with lypopolyssacharide (LPS)
found a pro-inflammatory effect of xenon [31]. The reason for
these discrepancies remains unclear. However, there are species,
stress and cell type differences between these studies and ours.
It should be pointed out that the attenuating effect of xenon on
early postoperative cognitive decline may also be modulated by
isoflurane anesthesia. This is because, like xenon, isoflurane may
have some anti-inflammatory effects. Previous studies showed that
pretreatment with isoflurane reduced microglial activation at
24 hours after LPS plus interferon gamma exposure in C8-B4
microglia [32]. Another inhalational anesthetic, sevoflurane,
induced an increase in expression of Hsp72 in cardiac muscle
[33]. We were unable to demonstrate similar changes with the
administration of isoflurane in terms of Hsp72 expression and
lower level of IL-1b in plasma. This could be secondary to inter-
species variability between mice and rabbits [33]. Nevertheless,
isoflurane anesthesia has been considered to be a risk factor for
cellular toxicity and cognitive decline as reported previously in vitro
[34] and in vivo [35,36,37] respectively or to induce proinflamma-
tory cytokine release in mice. (Wu et al., 2010)
Three limitations to our study should be noted: 1) A group of
animals pretreated with isoflurane followed by surgery or even a
Figure 2. Hippocampal dependent memory is impaired following treatment. A contextual conditional response, which is a form of
hippocampal dependent memory, was assessed as the percentage freezing time on days 1 (n = 12/group) and 7 (n = 12/group) after treatment. The
experimental animal groups are as described in the methods. Values are the mean 6 SEM. P values as indicated in the figures.
doi:10.1371/journal.pone.0026394.g002
Table 2. Hippocampal independent memory: Conditional response was assessed by.
Control 1.8% Iso 70% Xe 1.8% Iso-S Xe-Pretreat-Iso-S
Day 1 56.866.3% 130.868.4% 1128.367.4% 11128.965.9% 34.564.0%
Day 7 43.164.6% %19.664.5% 32.166.3% %%13.862.2% %%%15.562.6%
Data is presented as mean 6 SEM. Day 1: 1P= 0.57, 11P= 0.029, 111P= 0.034, Day 7: %P= 0.012, %%P= 0.052, %%%P= 0.017, all compared to control.
1.8% Iso = 1.8% isoflurane anesthesia treatment, 70% Xe = 70% xenon treatment, 1.8% Iso-S = 1.8% isoflurane surgery treatment, Xe-Pretreat-Iso-S = xenon pretreatment +1.8%
isoflurane anesthesia for surgery group.
doi:10.1371/journal.pone.0026394.t002
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group treated with xenon followed by isoflurane alone would
contribute to the understanding of our memory assessment
findings. 2) The surgical model used in our study is a very specific
iatrogenic injury generated under general anesthesia where other
variables were tightly controlled and which may not closely mimic
the clinical situation; 3) Adult rather than aged mice were used in
the assessment of postoperative memory decline after surgery
while POCD is more often to be seen in elderly patients.
Moreover, our tibial fracture model may not trigger a categorical
or pronounced behavioral change to those seen after exposure to
isoflurane alone. Also fracture trauma generated under general
anesthesia may not represent the insult seen in humans after
trauma. However, in view of the significant difference in behavior
seen after exposure to xenon, we consider it important to alert our
community about the potential risk or influence of anesthesia on
cognition after surgery. Despite these limitations, we did observe a
protective effect of xenon pretreatment on early postoperative
memory decline.
Conclusion
Our present data demonstrate that xenon exposure immediately
prior to surgery prevents early memory decline in mice, as assessed
by fear conditioning after tibial fracture surgery. This is associated
with a positive modulation of Hsp72 expression in the hippocam-
pus and a reduction in the plasma level of IL-1b. Our present
results thus raise the possibility that xenon anesthesia may reduce
the risk of early cognitive impairment following surgery.
Materials and Methods
The study was approved by the UK Home Office and conforms
to the United Kingdom Animals (Scientific Procedures) Act of
1986, PPL 70/6966, 19b 10.
Animals
C57BL/6 male mice (Harlan, Bicester, Oxon, UK) (1462
weeks old, weighing 25–30 g) were used in this study and were
housed in groups of five in a 12-h-12-h light dark cycle
Figure 3. Western blotting analysis of PI3-kinase in mouse
hippocampal tissue on day 1 after treatment. The experimental
animal groups are as described in the methods (n = 4/group). The top
panel shows a representative immunoblot for PI3-kinase that was
reprobed for a-tubulin as a loading control. The histogram in the
bottom panel shows the densitometric measurements of the PI3-kinase
signals on the immunoblot, relative to control. Values are the mean 6
SEM.
doi:10.1371/journal.pone.0026394.g003
Figure 4. Western blotting analysis of Hsp72 in mouse
hippocampal tissue on day 1 after treatment. The experimental
animal groups are as described in the methods (n = 6/group). The top
panel shows a representative immunoblot for Hsp72 that was reprobed
for a-tubulin as a loading control. The histogram in the bottom panel
shows the densitometric measurements of the Hsp72 signals on the
immunoblot, relative to control. Values are the mean 6 SEM.
doi:10.1371/journal.pone.0026394.g004
Figure 5. ELISA of plasma IL-1b levels on day 1 after treatment.
The experimental animal groups are as described in the methods (n = 4/
group). Values are the mean 6 SEM.
doi:10.1371/journal.pone.0026394.g005
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environment in which temperature and humidity were controlled.
The mice were allowed free access to food and water. The animal
holding and experimental room was maintained with temperature
at 20–22uC and humidity at 35–55%.
Conditional memory formation training
In our study, fear conditioning behavioral test paradigm has
been used to assess conditioned memory formation in the
hippocampus in our animal model. We consider this to be
analogous to common tests of memory utilized to assess memory
decline after surgery in humans. One day prior to treatment, the
animals were trained in fear conditioning to establish long-term
memory. Training and testing were performed in chambers with a
video camera positioned on one of the lateral walls to allow the
subjects’ behavior to be observed and recorded by an investigator,
both on- and off-line. The floor consisted of 32 stainless steel rods
(1 mm diameter), spaced 0.5 cm apart (center-to-center), and
wired to a shock generator and scrambler that delivered a
0.70 mA foot shock.
Training and testing for fear to the context took place in two
identical conditioning chambers (17.78619.05638.10 cm) housed
in sound attenuating box (Med Associates Inc, St Albans, VT).
The chambers were cleaned with a 5% sodium hydroxide solution
scented with 0.2% mint extract. Memory was established in the
preoperative period by exposing animals to the fear conditioning
chamber with background noise (60 dB) provided by a fan
positioned behind the chamber. Animals were acclimatized for
120 seconds before exposure to the training session that consisted
of six trials of paired conditional stimuli (tone, for 30 seconds at
90 dB) and unconditional stimuli (shock, for 2 seconds at
0.70 mA). Trace interval was 30 seconds between tone and shock,
with pseudorandom inter-training intervals of between 30 and
45 seconds. The total training time for each animal was
667 seconds. Hippocampal dependent memory and hippocampal
independent memory were assessed in a different context from
which the animals were trained.
Freezing was defined as the absence of any visible movement,
except that required for respiration (only fluctuation in the volume of
the thorax). The threshold for freezing was chosen according to the
individual animals motion index histogram, analyses being performed
by Video Freeze Version 2.1.0 (Med Associates Inc, St Albans, VT).
Recording starting 20 seconds after placing the animals in the
chamber, with a bout length of 0.75 seconds used in the algorithm to
identify episodes of freezing by the software. The percentage of
freezing-time, an indicator of memory formation, was assessed by an
independent operator for further statistical analysis using the video
recordings and tabulated data generated by the software.
Contextual memory assessment
Assessments of contextual memory formation and conditional
responses to test hippocampal dependent and independent
memory were performed in a novel context on days 1 and 7
after treatment, in a different cohort of animals for each
corresponding day [38]. The percentage of the total time spent
freezing (% freezing time) was used as an indicator of memory
formation during training and memory retrieval after surgery.
Hippocampal dependent memory was assessed by total freezing
time during exposure to a novel context [39,40] while hippocam-
pal independent memory was assessed by the percentage of
freezing time during exposure to the conditional stimulus (tone).
Anesthesia and surgery
Mice were allocated to 1 of 5 experimental groups (n = 12
mice/group) undergoing one of the following treatments
24 hours after training: 1) control - no treatment (Control); 2)
1.8% isoflurane anesthesia for 20 minutes (1.8% Iso); 3) 70%
xenon anesthesia balanced with nitrogen for 20 minutes (70%
Xe); 4) 1.8% isoflurane anesthesia with surgery of the right hind
leg tibia that was pinned and fractured (1.8% Iso-S); and 5)
pretreatment with 70% xenon for 20 minutes followed imme-
diately by 1.8% isoflurane anesthesia with surgery (Xe-pretreat-
Iso-S). The duration of surgery under anesthesia was approx-
imately 20 minutes in all cases. The anesthesia consisted of 1.8%
isoflurane in 30% oxygen balanced with nitrogen [41]. The
concentrations of isoflurane or xenon were monitored with a
Datex Ohmeda (GE Healthcare, Bradford, UK) and xenon
monitor (Air product, Oxon, UK), respectively. The surgical
model adopted in this study is based on that described previously
[42]. Briefly, under monitored isoflurane anesthesia, skin
incision was made below the knee and soft tissue was reflected
to expose bone through which a 0.3 mm stainless steel rod was
inserted into the medullary cavity. Once the tibia was internally
fixed, the bone was fractured in the mid-diaphysis (tibia, mid-
shaft) using surgical pliers. The wound was then closed using 2-0
Nylon sutures (Ethicon Inc, Somerville, NJ). A needle thermistor
was inserted into the subcutaneous tissue of the left leg.
Temperature was maintained at 37.060.4uC throughout these
experiments using a servo-controlled heating lamp and heating
pad. Mice were allowed to recover on heat pads and then
transferred to their own cages where food and water were
available. Post-surgery analgesia was provided using intraperi-
toneal (i.p.) buprenorphine, 0.03 mg/kg in saline and topical
eutectic mixture of local anesthesia (EMLA) twice daily for
72 hours.
Western blotting analysis
Both hippocampi from additional mouse cohorts (n = 6/group)
treated as described, but without behavioral testing, were
harvested 24 hours after treatment and homogenized (Polytron
homogenizer by Kinematrica, Bethlehem, PA) in iced- cold cell
lysis buffer (20 mM Tris-HCL, 150 mM NaCL, 1 mM
Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyro-
phosphate, 1 mM b-glycerolphosphate, 1 mM Na3VO4, 2 mM
DL-dithiothreitol, 1 mM phenylmethanesulphonyl , and 1 mg/ml
leupeptin, pH 7.5). The homogenates were centrifuged at
14,000 rpm for 10 minutes and the supernatants used for western
blotting after protein quantification. Each sample of 20 mg protein
in NuPageH SDS sample buffer (Invitrogen, Carlsbad, CA) was
separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE; Invitrogen) and transferred to a nitrocellu-
lose membrane (Hybond ECL, Amersham Biosciences, Little
Chalfont, UK). The membranes were blocked for 3 h in 5% non-
fat powdered milk in Tris-buffered saline/Tween (50 mM Tris
base, 150 mM NaCl, 0.1% Tween 20, pH 7.4) and then
incubated with Hsp70 (Hsp72) monoclonal antibody (C92F3A-5)
biotin conjugate (1:1000 dilution) (Stressgen assay designs, catalog
number: SPA-810B) or PI3-kinase p110 gamma antibody (1:1000
dilution) (Cell Signaling; Ref: 4252), overnight at 4uC. This was
followed by incubation with secondary horseradish peroxidase-
conjugated antibody. Protein bands were visualized using an
enhanced chemiluminescence system (Cell Signaling Technology,
Hertfordshire, UK). The membranes were then stripped and re-
incubated with monoclonal-anti-a-tubulin as a loading control
(1:1000 dilution). Protein bands were captured using the image
processor GeneSnap (Syngene, Cambridge, UK). Their density,
measured with GeneTools software (Syngene, Cambridge, UK),
was normalized using a-tubulin signals and expressed as ratio of
the control.
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ELISA
Blood was sampled transcardially after thoracotomy under
terminal isoflurane anesthesia in a separate animal cohort that
received the same treatments as the behavior-assessed groups.
Blood samples taken from treatment free animals served as
controls. Samples were centrifuged at 3,600 rpm for 30 minutes at
4uC and stored at 280uC prior to analysis. IL-1b was measured
using commercially available ELISA kits from Bender MedSys-
temsH (Ref: BMS6002). The sensitivity of the assay was 1.2 pg/ml.
Statistical analysis
Data are expressed as the mean6 SEM. All data were analyzed
using one-way analysis of variance (ANOVA) followed by Tukey’s
multiple comparison test to compare all groups (Prism 5 for Mac
OS X, Software, Inc). A Tukey multiple comparison test P
value,0.05 was considered statistically significant.
Acknowledgments
We thank Dr Helena Watts for her skill and invaluable assistance in
preparing the images, Dr Rosemary Snelgar for assistance with statistical
analysis and Professor Rona Giffard for comments and suggestions on the
manuscript.
Author Contributions
Conceived and designed the experiments: MV DL WY MP MM DM.
Performed the experiments: MV DL. Analyzed the data: MV DL DM.
Contributed reagents/materials/analysis tools: MV DL YWMPMMDM.
Wrote the paper: MV DL YW MP MM DM.
References
1. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, et al. (1998)
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study.
ISPOCD investigators. International Study of Post-Operative Cognitive
Dysfunction. Lancet 351: 857–861.
2. Ancelin ML, de Roquefeuil G, Ledesert B, Bonnel F, Cheminal JC, et al. (2001)
Exposure to anaesthetic agents, cognitive functioning and depressive symptom-
atology in the elderly. Br J Psychiatry 178: 360–366.
3. Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, et al. (2008)
Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesi-
ology 108: 18–30.
4. Boodhwani M, Rubens FD, Wozny D, Rodriguez R, Alsefaou A, et al. (2006)
Predictors of early neurocognitive deficits in low-risk patients undergoing on-
pump coronary artery bypass surgery. Circulation 114: I461–466.
5. Wan Y, Xu J, Ma D, Zeng Y, Cibelli M, et al. (2007) Postoperative impairment
of cognitive function in rats: a possible role for cytokine-mediated inflammation
in the hippocampus. Anesthesiology 106: 436–443.
6. Rosczyk HA, Sparkman NL, Johnson RW (2008) Neuroinflammation and
cognitive function in aged mice following minor surgery. Exp Gerontol 43:
840–846.
7. Barrientos RM, Higgins EA, Biedenkapp JC, Sprunger DB, Wright-Hardesty KJ,
et al. (2006) Peripheral infection and aging interact to impair hippocampal
memory consolidation. Neurobiol Aging 27: 723–732.
8. Barrientos RM, Frank MG, Hein AM, Higgins EA, Watkins LR, et al. (2009)
Time course of hippocampal IL-1 beta and memory consolidation impairments
in aging rats following peripheral infection. Brain Behav Immun 23: 46–54.
9. Terrando N, Rei Fidalgo A, Vizcaychipi M, Cibelli M, Ma D, et al. (2010) The
impact of IL-1 modulation on the development of lipopolysaccharide-induced
cognitive dysfunction. Crit Care 14: R88.
10. Rasmussen LS, Johnson T, Kuipers HM, Kristensen D, Siersma VD, et al.
(2003) Does anaesthesia cause postoperative cognitive dysfunction? A rando-
mised study of regional versus general anaesthesia in 438 elderly patients. Acta
Anaesthesiol Scand 47: 260–266.
11. Sun Y, Ouyang YB, Xu L, Chow AM, Anderson R, et al. (2006) The carboxyl-
terminal domain of inducible Hsp70 protects from ischemic injury in vivo and in
vitro. J Cereb Blood Flow Metab 26: 937–950.
12. Adori C, Kovacs GG, Low P, Molnar K, Gorbea C, et al. (2005) The ubiquitin-
proteasome system in Creutzfeldt-Jakob and Alzheimer disease: intracellular
redistribution of components correlates with neuronal vulnerability. Neurobiol
Dis 19: 427–435.
13. Giffard RG, Han RQ, Emery JF, Duan M, Pittet JF (2008) Regulation of
apoptotic and inflammatory cell signaling in cerebral ischemia: the complex
roles of heat shock protein 70. Anesthesiology 109: 339–348.
14. Zheng Z, Kim JY, Ma H, Lee JE, Yenari MA (2008) Anti-inflammatory effects
of the 70 kDa heat shock protein in experimental stroke. J Cereb Blood Flow
Metab 28: 53–63.
15. Vizcaychipi M, Xu L, Barreto G, Ma D, Maze M, Giffard R (2011) Hsp72
overexpression prevents early postoperative cognitive dysfunction following
orthopedic surgery under general anesthesia in mice. Anesthesiology 114:
891–900.
16. Kelly S, Zhang ZJ, Zhao H, Xu L, Giffard RG, et al. (2002) Gene transfer of
HSP72 protects cornu ammonis 1 region of the hippocampus neurons from
global ischemia: influence of Bcl-2. Ann Neurol 52: 160–167.
17. Limatola V, Ward P, Cattano D, Gu J, Giunta F, et al. (2010) Xenon
preconditioning confers neuroprotection regardless of gender in a mouse model
of transient middle cerebral artery occlusion. Neuroscience 165: 874–881.
18. Ma D, Yang H, Lynch J, Franks NP, Maze M, et al. (2003) Xenon attenuates
cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in
the rat. Anesthesiology 98: 690–698.
19. Clark JA, Ma D, Homi HM, Maze M, Grocott HP (2005) Xenon and the
inflammatory response to cardiopulmonary bypass in the rat. J Cardiothorac
Vasc Anesth 19: 488–493.
20. Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U (2005) Xenon attenuates
cerebral damage after ischemia in pigs. Anesthesiology 102: 929–936.
21. Ma DQ, Williamson P, Januszewski A, Nogaro MC, Hossain M, et al. (2007)
Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent
brain. Anesthesiology 106: 746–753.
22. Cattano D, Williamson P, Fukui K, Avidan M, Evers AS, et al. (2008) Potential
of xenon to induce or to protect against neuroapoptosis in the developing mouse
brain. Can J Anaesth 55: 429–436.
23. Yang YL, Lin MT (1999) Heat shock protein expression protects against
cerebral ischemia and monoamine overload in rat heatstroke. Am J Physiol 276:
H1961–1967.
24. Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, et al. (2001) Single
oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders
protection against ischemia/reperfusion injury in rat heart. Circulation 104:
1837–1843.
25. Ma D, Hossain M, Chow A, Arshad M, Battson R, et al. (2005) Xenon and
hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann
Neurol 58: 182–193.
26. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, et al. (2006) Xenon
preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb
Blood Flow Metab 26: 199–208.
27. Kang MJ, Jung SM, Kim MJ, Bae JH, Kim HB, et al. (2008) DNA-dependent
protein kinase is involved in heat shock protein-mediated accumulation of
hypoxia-inducible factor-1alpha in hypoxic preconditioned HepG2 cells. FEBS J
275: 5969–5981.
28. Saravanan P, Exley AR, Valchanov K, Casey ND, Falter F (2009) Impact of
xenon anaesthesia in isolated cardiopulmonary bypass on very early leucocyte
and platelet activation and clearance: a randomized, controlled study.
Br J Anaesth 103: 805–810.
29. Hein M, Roehl AB, Baumert JH, Bantes B, Bleilevens C, et al. (2008)
Establishment of a porcine right ventricular infarction model for cardiopro-
tective actions of xenon and isoflurane. Acta Anaesthesiol Scand 52:
1194–1203.
30. Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, et al. (2010) Role of
interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 68:
360–368.
31. Fahlenkamp AV, Coburn M, Haase H, Kipp M, Ryang YM, et al. (2011)
Xenon Enhances LPS-Induced IL-1beta Expression in Microglia via the
Extracellular Signal-Regulated Kinase 1/2 Pathway. J Mol Neurosci 45(1):
48–59.
32. Xu X, Kim JA, Zuo Z (2008) Isoflurane preconditioning reduces mouse
microglial activation and injury induced by lipopolysaccharide and interferon-
gamma. Neuroscience 154: 1002–1008.
33. Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (2008) Low-dose
sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug
geranylgeranylacetone. Anesth Analg 107: 755–761.
34. Xie Z, Dong Y, Maeda U, Alfille P, Culley D, et al. (2006) The common
inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta
protein levels. Anesthesiology 104: 988–994.
35. Culley DJ, Baxter MG, Yukhananov R, Crosby G (2004) Long-term impairment
of acquisition of a spatial memory task following isoflurane-nitrous oxide
anesthesia in rats. Anesthesiology 100: 309–314.
36. Bianchi S, Tran T, Liu C, Lin S, Li Y, et al. (2008) Brain and behavior changes
in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics.
Neurobiol Aging 29: 1002–1010.
37. Valentim AM, Alves HC, Silva AM, Olsson IA, Antunes LM (2008) Effects of
depth of isoflurane anaesthesia on a cognition task in mice. Br J Anaesth 101:
434–435.
38. Maren S, Aharonov G, Fanselow MS (1997) Neurotoxic lesions of the dorsal
hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res 88:
261–274.
Xenon and POCD
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e26394
39. Misane I, Tovote P, Meyer M, Spiess J, Ogren SO, et al. (2005) Time-dependent
involvement of the dorsal hippocampus in trace fear conditioning in mice.
Hippocampus 15: 418–426.
40. Raybuck JD, Lattal KM (2011) Double dissociation of amygdala and
hippocampal contributions to trace and delay fear conditioning. PloS one 6:
e15982.
41. Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, et al. (2003) The
neuroprotective effect of xenon administration during transient middle cerebral
artery occlusion in mice. Anesthesiology 99: 876–881.
42. Harry LE, Sandison A, Paleolog EM, Hansen U, Pearse MF, et al. (2008)
Comparison of the healing of open tibial fractures covered with either muscle or
fasciocutaneous tissue in a murine model. J Orthop Res 26: 1238–1244.
Xenon and POCD
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e26394
